login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
OLEMA PHARMACEUTICALS INC (OLMA) Stock News
NASDAQ:OLMA -
US68062P1066
-
Common Stock
5.77
USD
+0.23 (+4.15%)
Last: 8/22/2025, 3:39:47 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
OLMA Latest News, Press Relases and Analysis
All
Press Releases
2 days ago - By: Olema Oncology
Olema Oncology to Participate in Upcoming Investor Conferences
2 days ago - By: Olema Oncology
Olema Oncology to Participate in Upcoming Investor Conferences
11 days ago - By: Olema Oncology
Olema Oncology Reports Second Quarter 2025 Financial and Operating Results
11 days ago - By: Olema Oncology
Olema Oncology Reports Second Quarter 2025 Financial and Operating Results
18 days ago - By: Olema Oncology
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
18 days ago - By: Olema Oncology
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2 months ago - By: Olema Oncology
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2 months ago - By: Olema Oncology
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3 months ago - By: Olema Oncology
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3 months ago - By: Olema Oncology
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3 months ago - By: Benzinga
- Mentions:
BLRX
VSTM
VERA
TXMD
...
12 Health Care Stocks Moving In Monday's Intraday Session
3 months ago - By: Olema Oncology
Olema Oncology Announces Palazestrant Dose Selection and Trial-in-Progress Poster at ASCO 2025 Annual Meeting
3 months ago - By: Olema Oncology
Olema Oncology Announces Palazestrant Dose Selection and Trial-in-Progress Poster at ASCO 2025 Annual Meeting
3 months ago - By: Olema Oncology
Olema Oncology to Participate in Upcoming Investor Conferences
3 months ago - By: Olema Oncology
Olema Oncology to Participate in Upcoming Investor Conferences
3 months ago - By: Zacks Investment Research
Wall Street Analysts See a 386.42% Upside in Olema Pharmaceuticals (OLMA): Can the Stock Really Move This High?
3 months ago - By: Yahoo Finance
- Mentions:
PSX
TGT
PANW
MNSB
...
Elliott wins two seats, Phillips 66 retains two seats in hotly contested board fight
3 months ago - By: Olema Oncology
Olema Oncology Reports First Quarter 2025 Financial and Operating Results
3 months ago - By: Olema Oncology
Olema Oncology Reports First Quarter 2025 Financial and Operating Results
3 months ago - By: Benzinga
- Mentions:
ABTS
MTUS
SA
DEVS
...
Why Sable Offshore Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
3 months ago - By: Olema Oncology
Olema Oncology to Participate in Upcoming Investor Conferences
3 months ago - By: Olema Oncology
Olema Oncology to Participate in Upcoming Investor Conferences
4 months ago - By: Olema Oncology
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4 months ago - By: Olema Oncology
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4 months ago - By: Olema Oncology
Olema Oncology Announces New Preclinical Data for OP-3136 Demonstrating Anti-Tumor Activity in Multiple Solid Tumor Models at AACR 2025
4 months ago - By: Olema Oncology
Olema Oncology Announces New Preclinical Data for OP-3136 Demonstrating Anti-Tumor Activity in Multiple Solid Tumor Models at AACR 2025
4 months ago - By: Zacks Investment Research
Wall Street Analysts Think Olema Pharmaceuticals (OLMA) Could Surge 433.13%: Read This Before Placing a Bet
5 months ago - By: Olema Oncology
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
5 months ago - By: Olema Oncology
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
5 months ago - By: Olema Oncology
Olema Oncology to Present Preclinical Data for OP-3136, a Potent KAT6 Inhibitor, Demonstrating Anti-Tumor Activity in Multiple Solid Tumor Models at the 2025 AACR Annual Meeting
5 months ago - By: Olema Oncology
Olema Oncology to Present Preclinical Data for OP-3136, a Potent KAT6 Inhibitor, Demonstrating Anti-Tumor Activity in Multiple Solid Tumor Models at the 2025 AACR Annual Meeting
5 months ago - By: Olema Oncology
Olema Oncology Reports Fourth Quarter and Full Year 2024 Financial and Operating Results
5 months ago - By: Olema Oncology
Olema Oncology Reports Fourth Quarter and Full Year 2024 Financial and Operating Results
Please enable JavaScript to continue using this application.